Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

[1]  H. Farkas,et al.  Management of Hereditary Angioedema in Pediatric Patients , 2007, Pediatrics.

[2]  H. Farkas,et al.  C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients. , 2007, Molecular immunology.

[3]  O. Åkerblom,et al.  Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe. , 2006, The Journal of trauma.

[4]  M. Levi,et al.  Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. , 2006, The Journal of allergy and clinical immunology.

[5]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[6]  K. Bork,et al.  Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema , 2005, Transfusion.

[7]  A. Kaplan,et al.  Continuing Medical EducationAngioedema , 2005 .

[8]  S. Moore,et al.  Transfusion-related acute lung injury. , 2005, Transfusion.

[9]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[10]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[11]  William H. Yang,et al.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.

[12]  H. Farkas,et al.  Sex hormones in hereditary angioneurotic oedema , 2004, Clinical endocrinology.

[13]  J. Lindner,et al.  Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema: a review , 2003 .

[14]  H. Farkas,et al.  The Hungarian HAE experience. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[15]  C. Gilstad.  Anaphylactic transfusion reactions , 2003, Current opinion in hematology.

[16]  C. Drouet,et al.  Angioedema and Oral Contraception , 2003, Dermatology.

[17]  H. Farkas,et al.  Clinical management of hereditary angio‐oedema in children , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[18]  H. Farkas,et al.  Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema , 2001, European journal of gastroenterology & hepatology.

[19]  K. Bork,et al.  Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. , 2001, Archives of internal medicine.

[20]  M. Abinun.  Hereditary angio-oedema in children , 1999, The Lancet.

[21]  M. Cicardi,et al.  Plasma bradykinin in angio-oedema , 1998, The Lancet.

[22]  F. Rosen,et al.  A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema , 1998, Transfusion.

[23]  B. Stiller,et al.  Anaphylatoxins in fresh‐frozen plasma , 1997, Transfusion.

[24]  J. Bissler,et al.  Antibody to C1-inhibitor in a patient receiving C1-inhibitor infusions for treatment of hereditary angioneurotic edema with systemic lupus erythematosus reacts with a normal allotype of residue 458 of C1-inhibitor. , 1996, The Journal of laboratory and clinical medicine.

[25]  H. Burchardi,et al.  Die Anwendung eines C1-Inhibitorkonzentrats zur präoperativen Kurzzeitprophylaxe bei zwei Patienten mit hereditärem Angioödem , 1996, Der Anaesthesist.

[26]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[27]  D. Neurath,et al.  Red blood cell alloimmunization complicating plasma transfusion. , 1991, American journal of clinical pathology.

[28]  J. A. Grant,et al.  Hereditary angioedema: its diagnostic and management perspectives. , 1990, The American journal of medicine.

[29]  K. Bork,et al.  Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. , 1989, The Journal of allergy and clinical immunology.

[30]  A. Geha,et al.  Noncardiogenic pulmonary edema after cardiopulmonary bypass. An anaphylactic reaction to fresh frozen plasma. , 1984, American journal of surgery.

[31]  M. Cicardi,et al.  Hereditary Angioedema: An Appraisal of 104 Cases , 1982, The American journal of the medical sciences.

[32]  J. Atkinson,et al.  Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. , 1975, The Journal of allergy and clinical immunology.

[33]  V. Hawthorne,et al.  SCREENING FOR DISEASE , 1975, The Lancet.

[34]  H. Gewurz,et al.  Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. , 1969, Lancet.

[35]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[36]  B. Zuraw.  Current and future therapy for hereditary angioedema. , 2005, Clinical immunology.

[37]  A. Kaplan.  C1 inhibitor deficiency: hereditary and acquired forms. , 2001, Journal of investigational allergology & clinical immunology.

[38]  Angelo Agostoni,et al.  Drug-Induced Angioedema without Urticaria , 2001, Drug safety.

[39]  P. Spaeth,et al.  Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy. , 1993, International archives of allergy and immunology.